ING Groep NV Cuts Position in Humana Inc. (NYSE:HUM)

ING Groep NV trimmed its position in shares of Humana Inc. (NYSE:HUM) by 4.5% during the fourth quarter, Holdings Channel reports. The firm owned 15,379 shares of the insurance provider’s stock after selling 724 shares during the quarter. ING Groep NV’s holdings in Humana were worth $3,902,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of HUM. Creative Financial Designs Inc. ADV lifted its stake in Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 61 shares in the last quarter. Ashton Thomas Securities LLC acquired a new position in Humana in the 3rd quarter valued at about $31,000. Your Advocates Ltd. LLP increased its stake in Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 45 shares during the period. Atwood & Palmer Inc. lifted its position in shares of Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 60 shares in the last quarter. Finally, Kestra Investment Management LLC purchased a new position in shares of Humana in the fourth quarter valued at approximately $49,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

HUM has been the topic of several recent research reports. Wells Fargo & Company cut their target price on shares of Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research note on Monday, November 4th. JPMorgan Chase & Co. cut their price objective on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 18th. Barclays lifted their target price on Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Piper Sandler upped their price target on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a report on Wednesday, January 15th. Finally, Truist Financial lifted their price objective on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Nineteen analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $285.68.

Humana Trading Down 5.7 %

HUM opened at $255.77 on Friday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The business’s 50 day moving average is $269.41 and its two-hundred day moving average is $290.00. The firm has a market cap of $30.80 billion, a price-to-earnings ratio of 25.71, a price-to-earnings-growth ratio of 2.05 and a beta of 0.56.

Humana (NYSE:HUM) last announced its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, research analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, March 28th. This represents a $3.54 annualized dividend and a dividend yield of 1.38%. Humana’s dividend payout ratio (DPR) is 35.58%.

Insider Buying and Selling

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the sale, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.32% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.